HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Lind Selected Research

2,2',3,3',4,4',5-heptachlorobiphenyl

1/2019Association of Exposure to Persistent Organic Pollutants With Mortality Risk: An Analysis of Data From the Prospective Investigation of Vasculature in Uppsala Seniors (PIVUS) Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Lind Research Topics

Disease

71Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2002
47Insulin Resistance
01/2022 - 07/2002
42Obesity
01/2022 - 10/2002
37Inflammation (Inflammations)
01/2022 - 08/2003
35Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2008
32Hypertension (High Blood Pressure)
01/2021 - 01/2000
30Myocardial Infarction
12/2021 - 03/2003
29Atherosclerosis
01/2021 - 12/2002
21Heart Failure
01/2022 - 07/2007
18Stroke (Strokes)
01/2022 - 03/2002
17Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2012 - 04/2002
16Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 01/2006
14Coronary Disease (Coronary Heart Disease)
01/2019 - 08/2003
12Essential Hypertension
08/2009 - 01/2002
11Neoplasms (Cancer)
01/2022 - 08/2011
11Chronic Renal Insufficiency
12/2021 - 10/2009
9Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2009
9Overweight
11/2021 - 01/2010
8Ischemic Stroke
12/2021 - 12/2015
6Atrial Fibrillation
01/2021 - 12/2006
6Diabetes Mellitus
01/2019 - 07/2012
6Body Weight (Weight, Body)
01/2019 - 07/2004
5Dyslipidemias (Dyslipidemia)
01/2021 - 01/2002
5Carotid Artery Diseases
09/2020 - 04/2009
5Atherosclerotic Plaque (Atheroma)
01/2020 - 09/2011
5Hypertrophy
04/2013 - 03/2003
4Non-alcoholic Fatty Liver Disease
11/2021 - 01/2018
4Hyperinsulinism (Hyperinsulinemia)
03/2021 - 04/2003
4Necrosis
01/2021 - 03/2009
4Weight Loss (Weight Reduction)
01/2020 - 07/2003
4Cicatrix (Scar)
02/2017 - 07/2009
4Albuminuria
01/2017 - 01/2013
3COVID-19
01/2022 - 01/2021
3Heart Diseases (Heart Disease)
12/2021 - 10/2013
3Hyperglycemia
03/2021 - 05/2010
3Infarction (Infarctions)
01/2021 - 02/2015
3Acute Coronary Syndrome
10/2016 - 01/2009

Drug/Important Bio-Agent (IBA)

41Biomarkers (Surrogate Marker)IBA
04/2021 - 03/2009
33Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2003
33Glucose (Dextrose)FDA LinkGeneric
03/2021 - 08/2002
30LipidsIBA
12/2021 - 08/2002
29Insulin (Novolin)FDA Link
01/2022 - 07/2002
29Antihypertensive Agents (Antihypertensives)IBA
03/2017 - 01/2000
27CholesterolIBA
01/2021 - 03/2003
17LDL CholesterolIBA
12/2021 - 02/2006
16Triglycerides (Triacylglycerol)IBA
11/2021 - 02/2008
14AlbuminsIBA
12/2021 - 07/2002
14HDL CholesterolIBA
01/2021 - 10/2002
14C-Reactive ProteinIBA
11/2018 - 01/2007
13Persistent Organic PollutantsIBA
09/2020 - 08/2011
11CreatinineIBA
12/2021 - 01/2013
11ProinsulinIBA
11/2017 - 03/2003
11IrbesartanFDA LinkGeneric
08/2009 - 04/2002
11Atenolol (Tenormin)FDA LinkGeneric
08/2009 - 04/2002
10Growth Differentiation Factor 15IBA
02/2020 - 10/2009
10pro-brain natriuretic peptide (1-76)IBA
10/2018 - 04/2009
9Brain Natriuretic Peptide (Natrecor)FDA Link
12/2021 - 05/2011
9Polychlorinated Biphenyls (PCBs)IBA
09/2020 - 08/2011
9Troponin IIBA
01/2018 - 09/2008
9Blood Glucose (Blood Sugar)IBA
03/2017 - 07/2002
8Blood Proteins (Serum Proteins)IBA
12/2021 - 01/2017
8Biological ProductsIBA
12/2021 - 10/2010
8CalciumIBA
01/2021 - 06/2009
8Vitamin DFDA LinkGeneric
12/2018 - 06/2009
8Parathyroid Hormone (Parathormone)IBA
02/2015 - 06/2009
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2020 - 01/2012
7Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 07/2002
7AdiponectinIBA
09/2019 - 03/2009
6Pharmaceutical PreparationsIBA
12/2021 - 01/2008
6omega-Chloroacetophenone (Mace)IBA
01/2021 - 05/2013
6LeptinIBA
12/2020 - 12/2003
6HDL LipoproteinsIBA
02/2020 - 03/2004
6Cystatin CIBA
10/2016 - 01/2013
6ApolipoproteinsIBA
02/2014 - 03/2002
6MineralsIBA
05/2013 - 06/2009
5Hormones (Hormone)IBA
01/2022 - 01/2012
5Lipoproteins (Lipoprotein)IBA
12/2020 - 12/2001
5oxidized low density lipoproteinIBA
02/2020 - 12/2002
5EndostatinsIBA
10/2018 - 11/2013
5EnzymesIBA
10/2016 - 03/2009
5Angiotensin IIIBA
03/2004 - 05/2002
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 04/2013
4Cholesterol Esters (Cholesteryl Esters)IBA
12/2017 - 07/2002
4Apolipoproteins B (ApoB)IBA
01/2017 - 02/2006
4bisphenol AIBA
01/2017 - 09/2011
4Dichlorodiphenyl Dichloroethylene (DDE)IBA
03/2016 - 04/2012
4Indicators and Reagents (Reagents)IBA
10/2013 - 03/2012
4Fibroblast Growth Factor-23IBA
05/2013 - 10/2009
4Dietary Fats (Dietary Fat)IBA
12/2006 - 07/2002
3Carboxylic AcidsIBA
11/2021 - 01/2018
3LigandsIBA
01/2021 - 11/2017
3Protons (Proton)IBA
01/2021 - 04/2020
3Complement System Proteins (Complement)IBA
01/2020 - 06/2014
3Acetylcholine (Acetylcholine Chloride)FDA Link
10/2019 - 10/2007
3Linoleic Acid (Linoleate)IBA
01/2019 - 12/2006
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2018 - 01/2016
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2018 - 12/2015
3Phosphates (Orthophosphate)IBA
01/2017 - 11/2010
3Natriuretic PeptidesIBA
10/2016 - 04/2009

Therapy/Procedure

4Therapeutics
05/2013 - 04/2002